Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease

Area of Science:

• Molecular Biology
• Endocrinology
• Nephrology

Background:

• Diabetic kidney disease (DKD) is a major complication of diabetes mellitus.
• MicroRNAs (miRNAs) play critical roles in regulating gene expression and are implicated in DKD pathogenesis.
• Transforming growth factor beta (TGFβ) signaling is a key driver of fibrosis in DKD.

Purpose of the Study:

• To investigate the interaction between TGFβ-regulatory miRNAs and varying severities of DKD.
• To elucidate the molecular mechanisms underlying miRNA involvement in DKD-associated fibrosis.

Main Methods:

• Inclusion of 436 subjects stratified by urinary albumin-to-creatinine ratio (UACR).
• Culture of high glucose-induced renal microvascular cells (RMCs).
• Quantification of miRNAs, TGFβ1, and biochemical markers using real-time PCR, ELISA, and automated analysis.
• Bioinformatic prediction and visualization of miRNA target genes.

Main Results:

• Increased levels of HbA1c, TGFβ1, miR-217, and miR-224 correlated with higher UACR in type 2 diabetes mellitus (T2DM) patients.
• Decreased levels of miR-192 and miR-216a were observed with increasing UACR.
• High glucose and TGFβ1 modulated miRNA expression, with observed cross-regulation among miRNAs.
• Predicted miRNA targets are primarily involved in PTEN, PI3K/Akt, and MAPK signaling pathways.

Conclusions:

• TGFβ-regulatory miRNAs interact with DKD severity, potentially modulating fibrosis.
• These interactions are mediated through the PTEN, PI3K/Akt, and MAPK signaling pathways.
• Findings suggest novel therapeutic targets for DKD by modulating miRNA-TGFβ interactions.